]>
IRCT20210519051344N1 IRCT 2021-09-11 Tabriz University of Medical Sciences Studying the effect of combination topical therapy using three medications (Dorzolamide drops, Ketorolac drops, Prednisolone drops) in treatment of Ivrin Gass syndrome (CME) post cataract surgery Studying the effect of combination topical therapy using three medications (Dorzolamide drops, Ketorolac drops, Prednisolone drops) in treatment of Ivrin Gass syndrome (CME) post cataract surgery 2021-06-22 anticipated 30 Complete https://irct.ir/trial/56392 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. 2 Macular edema after uncomplicated cataract surgery. Intervention group: Among the patients referred to the Charity Eye Medical Center, Tabriz University of Medical Sciences, patients who have uncomplicated cataract surgery and have CME after surgery are included in the study if they wish and with the informed consent of the company. Drozolamide drops, ketorolac drops, prednisolone drops made in Sina Daru factory or other authorized factories, one drop 4 times a day for one month is prescribed. Patient vision, eye pressure, and macular thickness are measured 2, 4, and 8 weeks after treatment.. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is I have not decided yet
public Dr.Mojtaba Khalili
Abbasi
Tabriz Iran (Islamic Republic of) ۵۱۵۴۶۴۵۳۹۵ +98 41 3657 7330 Mojtabakhalili81@gmail.com Tabriz University of Medical Sciences scientific Dr.Afshin Lotfi Sadigh
Abbasi
Tabriz Iran (Islamic Republic of) ۵۱۵۴۶۴۵۳۹۵ +98 41 3657 7330 Lotfisadigh@tbzmed.ac.ir Tabriz University of Medical Sciences Iran (Islamic Republic of) Patient with CME after uncomplicated cataract surgery completing informed consent form to participate in the study no limit no limit Both Patients with diabetic retinopathy, retinal and vascular patients, patients with macular Patients with severe renal insufficiency, hepatic insufficiency, etc. are excluded from the study.degeneration are excluded from the study to control confounding variables. All patients admitted to the study can withdraw from the study at any time from the start of the study. Treatment - Drugs Intervention group: Among the patients referred to the Charity Eye Medical Center, Tabriz University of Medical Sciences, patients who have uncomplicated cataract surgery and have CME after surgery are included in the study if they wish and with the informed consent of the company. Drozolamide drops, ketorolac drops, prednisolone drops made in Sina Daru factory or other authorized factories, one drop 4 times a day for one month is prescribed. Patient vision, eye pressure, and macular thickness are measured 2, 4, and 8 weeks after treatment. Macular thickness. Timepoint: Treatment will continue for up to 2 months after starting treatment. If CME improves before this time, the patient will be examined for up to 8 weeks. The studied variables were patient vision before starting and 2, 4, 8 weeks after starting treatment, IOP before starting and 2, 4, 8 weeks after starting treatment and macular thickness before starting treatment and 2, 4 and 8 weeks after From the beginning of treatment. Method of measurement: Oct device and Goldman tonometer. Intraocular pressure. Timepoint: Treatment will continue for up to 2 months after starting treatment. If CME improves before this time, the patient will be examined for up to 8 weeks. The studied variables were patient vision before starting and 2, 4, 8 weeks after starting treatment, IOP before starting and 2, 4, 8 weeks after starting treatment and macular thickness before starting treatment and 2, 4 and 8 weeks after From the beginning of treatment. Method of measurement: Goldman Tonometer. Tabriz University of Medical Sciences Approved 2021-07-20 Ethics committee of Tabriz University of Medical Sciences Abbasi street Tabriz East Azarbaijan Iran (Islamic Republic of)